Yash R Somnay,Aili Wang,Haeun Lim,Keren K Griffiths,Fereshteh Zandkarimi,Kai Chen,Guang Yang,Andrzej Z Wasilczuk,Max B Kelz,David Larr,Mu Yang,Eva Gil-Iturbe,Anna Moon,Matthias Quick,Richard J Levy
{"title":"醌类似物泛醌-5对小鼠线粒体和催眠的影响。","authors":"Yash R Somnay,Aili Wang,Haeun Lim,Keren K Griffiths,Fereshteh Zandkarimi,Kai Chen,Guang Yang,Andrzej Z Wasilczuk,Max B Kelz,David Larr,Mu Yang,Eva Gil-Iturbe,Anna Moon,Matthias Quick,Richard J Levy","doi":"10.1097/aln.0000000000005549","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nA functional anesthetic target has long been suspected to reside within mitochondria and disruption of bioenergetic capacity is believed to play a role in the anesthetic response. Unfortunately, the exact mechanism by which changes in mitochondrial target activity result in clinically relevant anesthetic endpoints remains unknown. Here we leveraged knowledge of propofol toxicity to guide drug discovery and uncover a previously unknown pharmacological target within mitochondria. We hypothesized that, like propofol, quinone analogs would interfere with electron transfer, cause excessive proton leak within mitochondria, and induce hypnosis. We tested our hypothesis using the short-chain coenzyme Q (CoQ) analog, ubiquinone-5 (Ub5), and aimed to characterize its anesthetic phenotype in the mouse and elucidate the source of Ub5-induced mitochondrial leak.\r\n\r\nMETHODS\r\nAnesthetic phenotype was assessed in vivo in the mouse using behavioral and neurophysiological approaches. We measured biological activity in isolated mitochondria using polarography and spectrophotometry and identified source of proton leak using pharmacological inhibitors, mutant mouse strains, and transport activity assays in proteoliposomes. Finally, we assessed cardiotoxic effects in the isolated-perfused mouse heart ex-vivo.\r\n\r\nRESULTS\r\nCoQ analogs caused uncompensated proton leak in developing cardiomyocyte mitochondria and reversible cardiotoxicity in a manner reminiscent of propofol. Tail vein injection of Ub5 induced short-lived loss of righting, EEG changes consistent with a deep state of anesthesia, and reversible decreases in neuronal calcium transients and mitochondrial membrane potential (ΔΨm) in vivo. Precipitous decline in ΔΨm played a role in Ub5-induced unconsciousness and we identified the aspartate-glutamate carrier, Aralar, as a functional target and source of Ub5-mediated proton leak.\r\n\r\nCONCLUSIONS\r\nThe data indicate that uncompensated mitochondrial proton leak is an important mechanistic contributor to the anesthetic response in addition to electron transport inhibition. These findings advance our understanding of how anesthetics induce hypnosis and lay the foundation for next-generation drug discovery.","PeriodicalId":7970,"journal":{"name":"Anesthesiology","volume":"109 1","pages":""},"PeriodicalIF":9.1000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of the quinone analog, ubiquinone-5, on murine mitochondria and hypnosis.\",\"authors\":\"Yash R Somnay,Aili Wang,Haeun Lim,Keren K Griffiths,Fereshteh Zandkarimi,Kai Chen,Guang Yang,Andrzej Z Wasilczuk,Max B Kelz,David Larr,Mu Yang,Eva Gil-Iturbe,Anna Moon,Matthias Quick,Richard J Levy\",\"doi\":\"10.1097/aln.0000000000005549\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND\\r\\nA functional anesthetic target has long been suspected to reside within mitochondria and disruption of bioenergetic capacity is believed to play a role in the anesthetic response. Unfortunately, the exact mechanism by which changes in mitochondrial target activity result in clinically relevant anesthetic endpoints remains unknown. Here we leveraged knowledge of propofol toxicity to guide drug discovery and uncover a previously unknown pharmacological target within mitochondria. We hypothesized that, like propofol, quinone analogs would interfere with electron transfer, cause excessive proton leak within mitochondria, and induce hypnosis. We tested our hypothesis using the short-chain coenzyme Q (CoQ) analog, ubiquinone-5 (Ub5), and aimed to characterize its anesthetic phenotype in the mouse and elucidate the source of Ub5-induced mitochondrial leak.\\r\\n\\r\\nMETHODS\\r\\nAnesthetic phenotype was assessed in vivo in the mouse using behavioral and neurophysiological approaches. We measured biological activity in isolated mitochondria using polarography and spectrophotometry and identified source of proton leak using pharmacological inhibitors, mutant mouse strains, and transport activity assays in proteoliposomes. Finally, we assessed cardiotoxic effects in the isolated-perfused mouse heart ex-vivo.\\r\\n\\r\\nRESULTS\\r\\nCoQ analogs caused uncompensated proton leak in developing cardiomyocyte mitochondria and reversible cardiotoxicity in a manner reminiscent of propofol. Tail vein injection of Ub5 induced short-lived loss of righting, EEG changes consistent with a deep state of anesthesia, and reversible decreases in neuronal calcium transients and mitochondrial membrane potential (ΔΨm) in vivo. Precipitous decline in ΔΨm played a role in Ub5-induced unconsciousness and we identified the aspartate-glutamate carrier, Aralar, as a functional target and source of Ub5-mediated proton leak.\\r\\n\\r\\nCONCLUSIONS\\r\\nThe data indicate that uncompensated mitochondrial proton leak is an important mechanistic contributor to the anesthetic response in addition to electron transport inhibition. These findings advance our understanding of how anesthetics induce hypnosis and lay the foundation for next-generation drug discovery.\",\"PeriodicalId\":7970,\"journal\":{\"name\":\"Anesthesiology\",\"volume\":\"109 1\",\"pages\":\"\"},\"PeriodicalIF\":9.1000,\"publicationDate\":\"2025-05-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anesthesiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/aln.0000000000005549\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ANESTHESIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anesthesiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/aln.0000000000005549","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
Effects of the quinone analog, ubiquinone-5, on murine mitochondria and hypnosis.
BACKGROUND
A functional anesthetic target has long been suspected to reside within mitochondria and disruption of bioenergetic capacity is believed to play a role in the anesthetic response. Unfortunately, the exact mechanism by which changes in mitochondrial target activity result in clinically relevant anesthetic endpoints remains unknown. Here we leveraged knowledge of propofol toxicity to guide drug discovery and uncover a previously unknown pharmacological target within mitochondria. We hypothesized that, like propofol, quinone analogs would interfere with electron transfer, cause excessive proton leak within mitochondria, and induce hypnosis. We tested our hypothesis using the short-chain coenzyme Q (CoQ) analog, ubiquinone-5 (Ub5), and aimed to characterize its anesthetic phenotype in the mouse and elucidate the source of Ub5-induced mitochondrial leak.
METHODS
Anesthetic phenotype was assessed in vivo in the mouse using behavioral and neurophysiological approaches. We measured biological activity in isolated mitochondria using polarography and spectrophotometry and identified source of proton leak using pharmacological inhibitors, mutant mouse strains, and transport activity assays in proteoliposomes. Finally, we assessed cardiotoxic effects in the isolated-perfused mouse heart ex-vivo.
RESULTS
CoQ analogs caused uncompensated proton leak in developing cardiomyocyte mitochondria and reversible cardiotoxicity in a manner reminiscent of propofol. Tail vein injection of Ub5 induced short-lived loss of righting, EEG changes consistent with a deep state of anesthesia, and reversible decreases in neuronal calcium transients and mitochondrial membrane potential (ΔΨm) in vivo. Precipitous decline in ΔΨm played a role in Ub5-induced unconsciousness and we identified the aspartate-glutamate carrier, Aralar, as a functional target and source of Ub5-mediated proton leak.
CONCLUSIONS
The data indicate that uncompensated mitochondrial proton leak is an important mechanistic contributor to the anesthetic response in addition to electron transport inhibition. These findings advance our understanding of how anesthetics induce hypnosis and lay the foundation for next-generation drug discovery.
期刊介绍:
With its establishment in 1940, Anesthesiology has emerged as a prominent leader in the field of anesthesiology, encompassing perioperative, critical care, and pain medicine. As the esteemed journal of the American Society of Anesthesiologists, Anesthesiology operates independently with full editorial freedom. Its distinguished Editorial Board, comprising renowned professionals from across the globe, drives the advancement of the specialty by presenting innovative research through immediate open access to select articles and granting free access to all published articles after a six-month period. Furthermore, Anesthesiology actively promotes groundbreaking studies through an influential press release program. The journal's unwavering commitment lies in the dissemination of exemplary work that enhances clinical practice and revolutionizes the practice of medicine within our discipline.